Microbial reprogramming of immunogenic cell death:a new paradigm in tumor immunotherapyOA
Microbial reprogramming of immunogenic cell death:a new paradigm in tumor immunotherapy
Yilin Li;Huiyue Zhang;Yun Feng;Kun Fang;Yue Wang;Yuhang Zhou;Tao Sun;Junnan Xu
Department of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Central Laboratory,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Breast Medicine,Cancer Hospital of Dalian University of Technology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,ChinaDepartment of Breast Medicine 1,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Pharmacology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China||Department of Breast Medicine,Cancer Hospital of Dalian University of Technology,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China
Immunogenic cell deathdamage-associated molecular patternsmicrobiota and microbial metabolitestumor microenvironmentantitumor immune responses
Immunogenic cell deathdamage-associated molecular patternsmicrobiota and microbial metabolitestumor microenvironmentantitumor immune responses
《癌症生物学与医学（英文版）》 2026 (5)
657-677,21
This work was supported by the National Natural Science Foundation of China(Grant No.82373113,XJ),Natural Science Foundation of Liaoning Province(Grant No.2025-MSLH-421,XJ),LiaoNing Revitalization Talents Program(Grant No.XLYC1907160,XJ),Shenyang Breast Cancer Clinical Medical Research Center(Grant No.2020-48-3-1,ST),and Shenyang Public Health R&D Special Project(Grant No.22-321-31-04,ST).
评论